Custom Pharma Services
Mike Flower is an experienced professional with a strong background in quality assurance and regulatory compliance within the pharmaceutical industry. Currently serving as the Vice-Chair of Rudgwick Primary School's governing body since July 2018, Mike has also maintained a part-time, self-employed role as a Contract Qualified Person at Custom Pharma Services and Mediwin Limited since December 2012 and September 2015, respectively. Mike's extensive career includes pivotal positions such as QA Manager and Qualified Person at various pharmaceutical companies, including Fisher Clinical Services, Teva, Prova, Pfizer Pharmaceuticals, and SmithKline Beecham Animal Health, where responsibilities ranged from product release and quality management system oversight to managing analytical projects and ensuring compliance with GMP and GLP standards. Mike holds a MA/BA in Chemistry from the University of Cambridge and a BA in Computer Science from The Open University.
This person is not in any teams
Custom Pharma Services
1 followers
Custom Pharma Services is located in Brighton, UK since 1979 and is a full-service contract development and manufacturing organisation (CDMO) providing services tailored to your needs, no matter how niche or complex. Custom covers the full spectrum of activities from development through commercial manufacturing for both clinical and commercial use. Specialising in Oral Solid Dosage forms with the ability to handle highly potent drugs and poorly bioavailable compounds Custom really is your one stop resource. With direct access to highly skilled experts offering a partnership approach Custom Pharma Services truly has a molecule first mentality, managing all projects with the end in mind. Custom Can! • Custom Pharma is a CDMO offering clinical and commercial manufacturing of tablets, capsules, powders (oral-solid-dose) for human use. • Services comprise pre-formulation and formulation development, analytical development, stability testing, clinical trial material manufacturing • Commercial Production • Pre-clinical formulation development and solubilisation • Material characterisation • Drug in capsule approach to accelerate early clinical studies • Specialists in low dosage (sub-mg) formulations • Contained manufacturing for highly potent APIs • Orphan drug development • Formulation development of poorly soluble drugs, including spray drying capabilities